One of Biofarma's Investors Seeks To Sell Stake In Turkey Generics Maker
This article was originally published in PharmAsia News
Executive Summary
Turkey's Biofarma Pharmaceutical Industry says one of its investor co-owners has taken steps to find a buyer for its share of the maker of generic versions of heart, respiratory and urinary-tract drugs.